Ibrutinib,Tisagenlecleucel
janssen,novartis,abbvie
['tisagenlecleucel', 'fludarabine', ' ibru', 'tarmac', 'cyclophosphamide', 'tisa-cel', 'lymsm']
the study schema for the tarmac trial, combining ibrutinib &amp; tisa-cel - notably ibrutinib starts prior to leukapheresis with the hope of improving t-cell fitness #lymsm #ash22 
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer